1) Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer.

Ozkurt E, Yardımcı E, Tükenmez M, Ersoy YE, Yilmaz R, Cabioğlu N, Karanlık H, Kulle CB, Malya FU, Önder S, Gucin Z, İğci A, Özmen V, Dinççağ AS, Müslümanoğlu M.

2) Favorable Long-Term Outcome in Male Breast Cancer.

Özkurt E, Tükenmez M, Yılmaz R, Cabioğlu N, Müslümanoğlu M, Dinççağ AS, İğci A, Özmen V.

3) Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.

Cabıoğlu N, Karanlık H, Kangal D, Özkurt E, Öner G, Sezen F, Yılmaz R, Tükenmez M, Önder S, İğci A, Özmen V, Dinççağ A, Engin G, Müslümanoğlu M.

4) Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01.

Soran A, Ozmen V, Ozbas S, Karanlik H, Muslumanoglu M, Igci A, Canturk Z, Utkan Z, Ozaslan C, Evrensel T, Uras C, Aksaz E, Soyder A, Ugurlu U, Col C, Cabioglu N, Bozkurt B, Uzunkoy A, Koksal N, Gulluoglu BM, Unal B, Atalay C, Yıldırım E, Erdem E, Salimoglu S, Sezer A, Koyuncu A, Gurleyik G, Alagol H, Ulufi N, Berberoglu U, Dulger M, Cengiz O, Sezgin E, Johnson R.

5) Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up.

Özkurt E, Tükenmez M, Güven E, Çelet Özden B, Öner G, Müslümanoğlu M, İğci A, Özmen V, Küçücük S, Cabioğlu N.

6) Cost-Effectiveness of Breast Cancer Screening in Turkey, a Developing Country: Results from Bahçeşehir Mammography Screening Project.

Özmen V, Gürdal SÖ, Cabioğlu N, Özcinar B, Özaydın AN, Kayhan A, Arıbal E, Sahin C, Saip P, Alagöz O.

7) Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis.

Onder S, Fayda M, Karanlık H, Bayram A, Şen F, Cabioglu N, Tuzlalı S, İlhan R, Yavuz E.

8) Radiologic findings of screen-detected cancers in an organized population-based screening mammography program in Turkey.

Kayhan A, Arıbal E, Şahin C, Taşçı ÖC, Özkan Gürdal S, Öztürk E, Hatipoğlu HH, Özaydın N, Cabioğlu N, Özçınar B, Özmen V.

9) Perforated double appendicitis: Horseshoe type.

Bulut SP, Cabıoğlu N, Akıncı M.

10) Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey.

Özmen V, Atasoy A, Gökmen E, Özdoğan M, Güler N, Uras C, Ok E, Demircan O, Işıkkdoğan A, Cabioğlu N, Şen F, Saip P.

11) Successful first round results of a Turkish breast cancer screening program with mammography in Bahcesehir, Istanbul.

Kayhan A, Gurdal SO, Ozaydin N, Cabioglu N, Ozturk E, Ozcinar B, Aribal E, Ozmen V.

12) Factors predicting microinvasion in Ductal Carcinoma in situ.

Ozkan-Gurdal S, Cabioglu N, Ozcinar B, Muslumanoglu M, Ozmen V, Kecer M, Yavuz E, Igci A.

13) Comparison of intermittent pneumatic compression with manual lymphatic drainage for treatment of breast cancer-related lymphedema.

Gurdal SO, Kostanoglu A, Cavdar I, Ozbas A, Cabioglu N, Ozcinar B, Igci A, Muslumanoglu M, Ozmen V.

14) Survey on a mammographic screening program in Istanbul, Turkey.

Ozmen V, Nilufer Ozaydin A, Cabioglu N, Gulluoglu BM, Unalan PC, Gorpe S, Oner BR, Aribal E, Thomas DB, Anderson BO.

15) Breast cancer risk factors in Turkish women–a University Hospital based nested case control study.

Ozmen V, Ozcinar B, Karanlik H, Cabioglu N, Tukenmez M, Disci R, Ozmen T, Igci A, Muslumanoglu M, Kecer M, Soran A.

16) Increased lymph node positivity in multifocal and multicentric breast cancer.

Cabioglu N, Ozmen V, Kaya H, Tuzlali S, Igci A, Muslumanoglu M, Kecer M, Dagoglu T.

17) Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation.

Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES, Caffarella RS, Corbex M, Kreps GL, McTiernan A; Breast Health Global Initiative Early Detection Panel.

18) Is the thymidine labeling index a good prognostic marker in breast cancer?

Sen-Oran E, Ozmen V, Bilir A, Cabioglu N, Muslumanoglu M, Igci A, Guney N, Kecer M.

19) Manipulating the chemokine-chemokine receptor network to treat cancer.

Ruffini PA, Morandi P, Cabioglu N, Altundag K, Cristofanilli M.

20) Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.

Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F.

21) Fournier’s gangrene: risk factors and strategies for management.

Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N, Baspinar I.

22) Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.

Cabioglu N, Sahin A, Doucet M, Yavuz E, Igci A, O Yildirim E, Aktas E, Bilgic S, Kiran B, Deniz G,

23) CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer.

Cabioglu N, Yazici MS, Arun B, Broglio KR, Hortobagyi GN, Price JE, Sahin A.

24) CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cabioglu N, Summy J, Miller C, Parikh NU, Sahin AA, Tuzlali S, Pumiglia K, Gallick GE, Price JE.

25) Idiopathic necrotizing fasciitis: risk factors and strategies for management.

Taviloglu K, Cabioglu N, Cagatay A, Yanar H, Ertekin C, Baspinar I, Ozsut H, Guloglu R.

26) Improving local control with breast-conserving therapy: a 27-year single-institution experience.

Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F.

27) Feasibility of surgical management in patients with granulomatous mastitis.

Asoglu O, Ozmen V, Karanlik H, Tunaci M, Cabioglu N, Igci A, Selcuk UE, Kecer M.

28) Thymidine labeling index: prognostic role in breast cancer.

Bilir A, Ozmen V, Kecer M, Eralp Y, Cabioglu N, Ahishali B, Camlica H, Aydiner A.

29) Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.

Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV.

30) T-cell lymphoblastic lymphoma presenting with a breast mass.

Yumuk PF, Aydiner A, Topuz E, Cabioglu N, Dogan O.

31) Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge.

Cabioglu N, Hunt KK, Singletary SE, Stephens TW, Marcy S, Meric F, Ross MI, Babiera GV, Ames FC, Kuerer HM.

32) Inflammatory breast cancer: results of antracycline-based neoadjuvant chemotherapy.

Ozmen V, Cabioglu N, Igci A, Dagoglu T, Aydiner A, Kecer M, Bozfakioglu Y, Dinçer M, Bilir A, Topuz E.

33) Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer.

Ozmen V, Muslumanoglu M, Cabioglu N, Tuzlali S, Ilhan R, Igci A, Kecer M, Bozfakioglu Y, Dagoglu T.

34) An ultrasensitive tumor enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer.

Cabioglu N, Igci A, Yildirim EO, Aktas E, Bilgic S, Yavuz E, Muslumanoglu M, Bozfakioglu Y, Kecer M, Ozmen V, Deniz G.

35) Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis.

Cabioglu N, Bilgic S, Deniz G, Aktas E, Seyhun Y, Turna A, Gunay K, Esen F.